| 1 |
Wu S, Li Y, Mishra S, Bodner K, Baral S, Kwong JC, Wei X. Effect of the incremental protection of previous infection against Omicron infection among individuals with a hybrid of infection- and vaccine-induced immunity: a population-based cohort study in Canada. Int J Infect Dis 2023;127:69-76. [PMID: 36455812 DOI: 10.1016/j.ijid.2022.11.028] [Reference Citation Analysis]
|
| 2 |
Thompson RN, Southall E, Daon Y, Lovell-Read FA, Iwami S, Thompson CP, Obolski U. The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants. Front Immunol 2022;13:1049458. [PMID: 36713397 DOI: 10.3389/fimmu.2022.1049458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 3 |
Zhao L, Santiago F, Rutter EM, Khatri S, Sindi SS. Modeling and Global Sensitivity Analysis of Strategies to Mitigate Covid-19 Transmission on a Structured College Campus. Bull Math Biol 2023;85:13. [PMID: 36637563 DOI: 10.1007/s11538-022-01107-2] [Reference Citation Analysis]
|
| 4 |
Verma A, Goel A, Katiyar H, Tiwari P, Mayank, Sana A, Khetan D, Bhadauria DS, Raja A, Khokher N, Shalimar, Singh RK, Aggarwal A. Durability of ChAdOx1 nCoV-19 (Covishield(®)) Vaccine Induced Antibody Response in Health Care Workers. Vaccines (Basel) 2022;11. [PMID: 36679930 DOI: 10.3390/vaccines11010084] [Reference Citation Analysis]
|
| 5 |
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen. Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ Vaccines 2022;7:167. [PMID: 36535982 DOI: 10.1038/s41541-022-00597-4] [Reference Citation Analysis]
|
| 6 |
Rahman F, Mazumder S, Farook S, Deb P, Saha SP, Akter F, Jilani MSA, Haq JA. Antibody response to receptor-binding domain of SARS-CoV-2 spike protein following vaccination and natural infection with SARS-CoV-2. IMC Journal of Medical Science 2022. [DOI: 10.55010/imcjms.17.009] [Reference Citation Analysis]
|
| 7 |
Miyasaka M. The lymphatic system and COVID-19 vaccines. Front Immunol 2022;13:1041025. [DOI: 10.3389/fimmu.2022.1041025] [Reference Citation Analysis]
|
| 8 |
Thompson R, Southall E, Daon Y, Lovell-read F, Iwami S, Thompson C, Obolski U. The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.. [DOI: 10.1101/2022.09.20.22280161] [Reference Citation Analysis]
|
| 9 |
Mahla RS, Dustin LB. Lessons from a large-scale COVID-19 vaccine trial. Journal of Clinical Investigation 2022;132:e163202. [DOI: 10.1172/jci163202] [Reference Citation Analysis]
|
